Clinical
RSSArticles
-
Oral Progestogens for Prevention of Miscarriage
In this double-blind, randomized clinical trial, 406 pregnant women were randomized to dydrogesterone or placebo. There were no statistically significant differences in the primary outcome (miscarriage before 20 weeks of gestation; relative risk, 0.897; 95% confidence interval, 0.548-1.467; P = 0.772), which occurred in 12.8% and 14.3% in the dydrogesterone and placebo arms, respectively. The use of dydrogesterone in women with threatened miscarriage for the prevention of early pregnancy loss in the first trimester failed to decrease the miscarriage rate or increase the live birth rate.
-
Is HPV Testing Superior to Pap Testing Alone in Women at Risk of Cervical Cancer?
In this registry-based screening study of women in Catalonia, Spain, a negative human papillomavirus (HPV) and cytology co-test at baseline was associated with a cumulative incidence of cervical precancer of 0.4% at five years and 1.3% at nine years, compared to 27% among women with abnormal HPV testing at baseline.
-
Pregnancy After Treatment for Pelvic Floor Disorders
This consensus document was developed as a reference for physicians caring for and advising women in pregnancy following prior surgical treatment for pelvic floor disorders.
-
The Pregnancy Perspective: What Has COVID-19 Affected?
In this cross-sectional descriptive study, women using the Ovia pregnancy app expressed receiving adequately safe maternal care during the COVID-19 pandemic, but voiced concerns related to obtaining infant supplies and prenatal education.
-
New Guidelines Reinforce Need for Change in Cervical Cancer Screening Practice
Screening standards for cervical cancer have changed over the past two decades, including several updates since the first consensus guidelines, published in 2001 by the American Society of Colposcopy and Cervical Pathology. The 2020 revision is based on data showing that patients’ risk of developing cervical precancer or cancer can be estimated using screening test results, biopsy results, and consideration of personal patient factors.
-
Educational Sessions for Women with Opioid Use Disorder Improve Engagement
A Maine family planning clinic launched a program to reach women who experience barriers to reproductive healthcare, counseling, and testing for sexually transmitted infections. The program focused on outreach, sending an educator to various locations and providing an educational session for women who are especially vulnerable, including those who use opioids.
-
Study: Risk Assessment for Contraceptives Is Influenced by Cultural Biases
Cultural assumptions create unbalanced risk assessment when the medical community weighs the risks and benefits of common contraceptive methods, the authors of a recent study concluded. Researchers studied contraception risks and assessed how these risks were prioritized in reproductive health providers’ understanding of contraceptives and their potential side effects.
-
Study: Contraception Program for Incarcerated Women Can Prevent Pregnancies
An estimated 5% of women in jails are pregnant, and human rights groups and researchers have collected evidence that these women often receive poor care and are neglected. One solution is to provide contraceptive care to incarcerated women who would like to avoid pregnancy.
-
Contraceptive Use Is Less Consistent for Young Women Experiencing Hardships
Researchers studied more than 1,000 women, ages 18 and 19 years, over several years, asking them weekly questions about their contraceptive use, sex, and pregnancy. They found that women who experience material hardship use contraceptives less consistently.
-
Researchers Study Immigrant Latinas’ Experience with Reproductive Healthcare
Latina-identified immigrants experience multiple barriers to healthcare, including contraception and reproductive care. This can result in lack of access to affordable preventive screenings, such as Pap smears, mammograms, and tests for sexually transmitted infections, according to the authors of a recent study.